Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs ...

Voyager Therapeutics said it will assess alternate payloads related to its gene therapeutic program related to a form of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

INTEGRA Biosciences offers liquid handling solutions and magnetic modules to streamline every stage of NGS sample preparation ...

Our Solar System, like a sneaky little hobbit, seems to have stuffed its pockets full of hidden oceans. Jupiter, Saturn, ...

Anthos Therapeutics, based in Cambridge, has a drug in late-stage clinical trials aimed at preventing strokes and blood clots ...

ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

NASA has explored the space beyond Earth and our solar system with spacecraft like Voyagers 1 and 2, and how we’ve discovered ...

On Valentines Day in 1990, NASAs Voyager 1 captured the iconic ‘Pale Blue Dot image, showing Earth as a tiny speck from 3.7 ...

On this day 35 years ago, NASA's Voyager 1 spacecraft took a picture that changed how we see our planet. The iconic "Pale Blue Dot" image is just as awe-inspiring today.

Despite the setback with VY9323, Voyager Therapeutics anticipates IND filings in 2025 for gene therapy candidates targeting GBA1 Parkinson’s and other GBA1-mediated diseases, as well as Friedreich’s ...